Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01435122 · OUTCOME

24 Month Overall Survival (OS) Rate

A Study of Axitinib in Advanced Carcinoid Tumors · Source last updated 2018-10-02

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
percentage of participants
Interval / dispersion
Not reported
Time frame
24 months

What was measured

Overall survival by Kaplan Meier, determined from the time of drug administration to death from any cause. The effect of an intervention is assessed by measuring the number of subjects survived or saved after that intervention over a period of time. The time starting from a defined point to the occurrence of a given event, for example death is called as survival time and the analysis of group data as survival analysis.

Analysis population: All participants

Groups in this outcome

Axitinib Administration

The investigational drug used in this study is axitinib, and is available as tablets.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Axitinib Administration30

Reported measurements

Source class 1
Values in percentage of participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Axitinib Administration74.3Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        74.3
denoms
  1. counts
    1. group Id
      OG000
      value
      30
    units
    Participants
description
Overall survival by Kaplan Meier, determined from the time of drug administration to death from any cause. The effect of an intervention is assessed by measuring the number of subjects survived or saved after that intervention over a period of time. The time starting from a defined point to the occurrence of a given event, for example death is called as survival time and the analysis of group data as survival analysis.
groups
  1. description
    The investigational drug used in this study is axitinib, and is available as tablets.
    id
    OG000
    title
    Axitinib Administration
param Type
NUMBER
population Description
All participants
reporting Status
POSTED
time Frame
24 months
title
24 Month Overall Survival (OS) Rate
type
SECONDARY
unit Of Measure
percentage of participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice